Your browser doesn't support javascript.
loading
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.
Blakemore, Stuart J; Clifford, Ruth; Parker, Helen; Antoniou, Pavlos; Stec-Dziedzic, Ewa; Larrayoz, Marta; Davis, Zadie; Kadalyayil, Latha; Colins, Andrew; Robbe, Pauline; Vavoulis, Dimitris; Forster, Jade; Carr, Louise; Morilla, Ricardo; Else, Monica; Bryant, Dean; McCarthy, Helen; Walewska, Renata J; Steele, Andrew J; Chan, Jacqueline; Speight, Graham; Stankovic, Tanja; Cragg, Mark S; Catovsky, Daniel; Oscier, David G; Rose-Zerilli, Matthew J J; Schuh, Anna; Strefford, Jonathan C.
Afiliação
  • Blakemore SJ; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Clifford R; Department I of Internal Medicine, Centre of Excellence in Aging Research, University of Cologne, Cologne, Germany.
  • Parker H; Oxford National Institute for Health Research Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, UK.
  • Antoniou P; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Stec-Dziedzic E; Oxford National Institute for Health Research Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, UK.
  • Larrayoz M; Oxford National Institute for Health Research Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, UK.
  • Davis Z; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Kadalyayil L; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Colins A; Genetic Epidemiology and Bioinformatics, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Robbe P; Genetic Epidemiology and Bioinformatics, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Vavoulis D; Oxford National Institute for Health Research Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, UK.
  • Forster J; Oxford National Institute for Health Research Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, UK.
  • Carr L; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Morilla R; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Else M; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Bryant D; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • McCarthy H; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Walewska RJ; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Steele AJ; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Chan J; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Speight G; Oxford Gene Technology, Begbroke Science Park, Begbroke, Oxfordshire, UK.
  • Stankovic T; Oxford Gene Technology, Begbroke Science Park, Begbroke, Oxfordshire, UK.
  • Cragg MS; Institute of Cancer and Genomic Sciences, College of Medical and Dental Services, IBR West, University of Birmingham, Birmingham, UK.
  • Catovsky D; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Oscier DG; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
  • Rose-Zerilli MJJ; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Schuh A; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Strefford JC; Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Leukemia ; 34(7): 1760-1774, 2020 07.
Article em En | MEDLINE | ID: mdl-32015491
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Sistema de Sinalização das MAP Quinases / Proteínas Mutadas de Ataxia Telangiectasia / Proteína 3 com Repetições IAP de Baculovírus / Mutação Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Biomarcadores Tumorais / Proteína Supressora de Tumor p53 / Sistema de Sinalização das MAP Quinases / Proteínas Mutadas de Ataxia Telangiectasia / Proteína 3 com Repetições IAP de Baculovírus / Mutação Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido